SANTA MONICA, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will host a conference call and live webcast discussion at 4:30 p.m. Eastern Time on Monday, August 10, 2015, to discuss financial results for the second quarter ended June 30, 2015, and provide a business update.
To access the live conference call via phone, please dial (844) 856-8656. International callers may access the live call by dialing (443) 877-4062. The conference ID number for the live call is 98583072.
The live and archived webcast can be accessed through the Calendar of Events section of the Company's website at ir.kitepharma.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software. A replay of the webcast will be available on the Company's website for two weeks following the event.
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.
CONTACT: Kite Pharma Cynthia M. Butitta Chief Financial Officer and Chief Operating Officer 310-824-9999 For Media: Justin Jackson For Investor Inquiries: Lisa Burns and Carol Werther Burns McClellan 212-213-0006 firstname.lastname@example.org email@example.com firstname.lastname@example.org
Source:Kite Pharma, Inc.